Transparent to the transcendent.
Wrote a book on Long Covid. - https://t.co/EulMyWl4cr
Extraordinary claims require extraordinary evidence. - Sagan
Dec 22, 2024 • 17 tweets • 3 min read
What if the NIH focused on basic science and testing existing COVID treatments instead of studies on melatonin and light therapy?
Articles like this are frustrating because they highlight the waste in treating symptoms without addressing the root cause.
kevinmd.com/2024/12/long-c…
It’s astonishing that massive trials can continue despite patient protests and clear evidence showing resources should be redirected.
It seems no one wants to confront the hard truth, even when we could reinvest in more worthwhile projects.
Nov 22, 2024 • 20 tweets • 7 min read
Michael Peluso on viral persistence at Demystifying Long COVID International 2024
Small thread 🧵
1/ "At the beginning of the pandemic I was not a believer in SARS-CoV-2 persistence, but have now become more convinced with data emerging"
Nov 21, 2024 • 21 tweets • 3 min read
Demystifying Long COVID International Conference 2024.
Mini-thread as most content is repeated from earlier this year. 🧵
1/ Introduction covered the importance of Long COVID. Mostly building on-top of Peluso/Deeks recent mechanisms paper.
Various sessions on how Long COVID impacts various cohorts and systems.
Will post interesting posters real quick:
Nov 13, 2024 • 5 tweets • 3 min read
I’m open-sourcing a multi-agent Long COVID project from my Master’s Program at UT Austin to explore the disease’s mechanisms, suggest interventions, and test combination treatments.
Example of interventions identified for each model:
Nov 8, 2024 • 58 tweets • 43 min read
PolyBio Fall Symposium 2024 thread 🧵
1/
Amy Proal introduces the Fall Symposium. PolyBio is a non-profit org building a collective to solve diseases like Long COVID, ME/CFS, and more
They recently published a new project page to see how these projects map to the human body
🧬 MENSA tech uses new antibodies to detect ongoing COVID-19 & viral reactivations in #LongCOVID. With 60% accuracy for SCV2, EBV, CMV, HSV2, it offers diagnostics from a single blood sample.
Differentiates between infection and vaccination responses.
- Accurate detection of viral persistence
- Identification of latent reactivation
- Single blood sample
- High sensitivity & specificity
- Distinguishes infection & vaccination
- Extend to other chronic illnesses
- Non-invasive
- Clinical biomarker
Jun 6, 2024 • 44 tweets • 6 min read
Demystifying Long COVID North American Conference 2024
🧵of my personal opinions on discussion points
1/ The sincerity of this problem is being addressed by many partners around the world. The NIH, CDC, public & private research, etc